Bio-Techne

Yahoo Finance • 2 days ago

Notable healthcare headlines for the week: Novo Nordisk, Hims & Hers and UnitedHealth in focus

Wall Street finished the week on a strong note as all three major market averages tagged record levels on Friday. For the week, the Nasdaq (COMP:IND), S&P 500 (SP500), and Dow (DJI) rose by 2.21%, 1.22%, and 1.05%, respectively. The S&P... Full story

Yahoo Finance • 8 days ago

RxSight (RXST) Fell Due to Missed Expectations and Guidance Reduction

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The small-cap US stocks rebounded... Full story

Yahoo Finance • 8 days ago

Here’s Why The Brown Capital Small Company Fund is Re-Evaluating Bio-Techne’s (TECH) Long-Term Growth Profile

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The small-cap US stocks rebounded... Full story

Yahoo Finance • 11 days ago

Exploring the top movers within the S&P500 index during today's session.

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. [topmovers] GAINERS TICKER CHANGE COMMENT WBD [https://www.chartmill.com/stock/quote/WBD/profile] 14.69% WARNER BROS DISC... Full story

Yahoo Finance • 13 days ago

Which S&P500 stocks are moving on Wednesday?

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE C... Full story

Yahoo Finance • 18 days ago

Exelixis, Inc. (EXEL): A Bull Case Theory

We came across a bullish thesis on Exelixis, Inc. on Investing With Purpose’s. In this article, we will summarize the bulls’ thesis on EXEL. Exelixis, Inc.'s share was trading at $37.42 as of August 29th. EXEL’s trailing and forward P/E we... Full story

Yahoo Finance • 21 days ago

Why Bio-Techne (TECH) Shares Are Sliding Today

What Happened? Shares of life sciences company Bio-Techne (NASDAQ:TECH) fell 3.3% in the afternoon session after the major indices continued to retreat (Nasdaq -1.5%, S&P 500 -1.2%) amid profit-taking and renewed concerns about tariffs. T... Full story

Yahoo Finance • 26 days ago

Thursday Sector Laggards: Consumer Products, Healthcare

The worst performing sector as of midday Thursday is the Consumer Products sector, showing a 1.0% loss. Within that group, Hormel Foods Corp. (Symbol: HRL) and Brown-Forman Corp (Symbol: BF.B) are two large stocks that are lagging, showin... Full story

Yahoo Finance • 27 days ago

ADMA Biologics, Inc. (ADMA): A Bull Case Theory

We came across a bullish thesis on ADMA Biologics, Inc. on Archive Invest’s Substack by Felix. In this article, we will summarize the bulls’ thesis on ADMA. ADMA Biologics, Inc.'s share was trading at $17.80 as of August 22nd. ADMA’s trail... Full story

Yahoo Finance • 30 days ago

Notable healthcare headlines for the week: Novo Nordisk, Medtronic, Novavax in focus

Wall Street jumped sharply on Friday, with the Dow hitting a fresh all-time high as investors welcomed Federal Reserve Chair Jerome Powell’s remarks at Jackson Hole. The S&P 500 Health Care Index Sector (NYSEARCA:XLV [https://seekingalpha... Full story

Yahoo Finance • last month

CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Morgan Stanley upgraded HP Enterprise(... Full story

Yahoo Finance • last month

Techstep Q2 2025 slides: Profitability rises 64% despite revenue dip

Introduction & Market Context Techstep ASA (OB:TECH), a European mobile and circular technology company, presented its Q2 2025 financial results on August 20, 2025, highlighting improved profitability despite a revenue decline. The compan... Full story

Yahoo Finance • 2 months ago

Earnings call transcript: Bio-Techne Q4 2025 beats EPS forecasts

Bio-Techne Corp (TECH) reported its fourth-quarter earnings for fiscal year 2025, surpassing analysts’ expectations with an adjusted earnings per share (EPS) of $0.53, compared to the forecasted $0.50. Revenue reached $317 million, slightl... Full story

Yahoo Finance • 2 months ago

Bio-Techne Corp (NASDAQ:TECH) Reports Mixed Q4 2025 Earnings Amid Revenue Miss and EPS Beat

Bio-Techne Corp (NASDAQ:TECH [https://www.chartmill.com/stock/quote/TECH]) reported its fourth-quarter fiscal 2025 earnings, delivering mixed results compared to analyst expectations. The company's performance, along with the market's reac... Full story

Yahoo Finance • 2 months ago

Bio-Techne announces Exosome Diagnostics divestiture

* Bio-Techne (NASDAQ:TECH [https://seekingalpha.com/symbol/TECH]) on Tuesday announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics business, including the ExoDx Prostate (EPI [https://seekingalpha.com/symbol/EPI]... Full story

Yahoo Finance • 2 months ago

Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow

Life sciences company Bio-Techne (NASDAQ:TECH) will be reporting results this Wednesday before market open. Here’s what investors should know. Bio-Techne met analysts’ revenue expectations last quarter, reporting revenues of $316.2 millio... Full story

Yahoo Finance • 2 months ago

Abeona Therapeutics lowers loan interest rate and issues warrants in loan amendment

Abeona Therapeutics Inc. (NASDAQ:ABEO) announced Friday that it has amended its existing Loan and Security Agreement with Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P. The amendment reduces the inte... Full story

Yahoo Finance • 2 months ago

Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH)

Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio bounced back from the first quarter uncertainty and, like the res... Full story

Yahoo Finance • 2 months ago

H.C. Wainwright maintains Buy rating on Abeona Therapeutics stock despite FDA setback

Investing.com - H.C. Wainwright has reiterated its Buy rating and $20.00 price target on Abeona Therapeutics (NASDAQ:ABEO), currently trading at $5.74 with a market cap of $294 million, following the FDA’s Complete Response Letter (CRL) fo... Full story

Yahoo Finance • 3 months ago

Renk CEO calls for defense industry consolidation to boost Europe’s military competitiveness

[Close-up of toy tanks against the background of unfolded euro notes and the European flag] Olena Bartienieva/iStock via Getty Images Europe’s defense industry needs to consolidate to enhance its competitiveness as it scales up production... Full story